Navigation Links
Venaxis to Provide Third Quarter 2013 Business Update
Date:10/31/2013

CASTLE ROCK, Colo., Oct. 31, 2013 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1™ Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced it will provide a third quarter business update on Thursday, November 7, 2013, at 8:30 a.m. ET.  The conference call will be hosted by Steve Lundy, Chief Executive Officer; Jeff McGonegal, Chief Financial Officer; and Don Hurd, Senior Vice President and Chief Commercial Officer.

Interested participants and investors may access the conference call by dialing 1 (877) 870-4263 (U.S.), 1 (855) 669-9657 (Canada) or 1 (412) 317-0790 (international).  A live audio webcast will be accessible via the Investor Relations section of the Venaxis™ web site, ir.venaxis.com.  

A telephonic replay of the call will be available for 90 days beginning approximately on hour after the end of the conference call through February 7, 2014.  Access numbers for this replay are 1 (877) 344-7529 (U.S./Canada) and 1 (412) 317-0088 (international); conference ID: 10036520.  The webcast replay will remain available in the Investors Relations section of the Venaxis web site for 90 days.

About Venaxis, Inc.
Venaxis, Inc. is an in vitro diagnostic company focused on the clinical development and commercialization of its CE Marked APPY1 Test, the Company's rapid, protein biomarker-based assay for appendicitis.  This unique appendicitis test has projected high sensitivity and negative predictive value and is being developed to aid in the identification of patients at low risk for acute appen
'/>"/>

SOURCE Venaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AspenBio Pharma Changes Company Name to Venaxis, Inc.
2. Venaxis to Present at 2013 BIO CEO and Investor Conference
3. Venaxis Presentation Rescheduled for 2013 BIO CEO and Investor Conference
4. Venaxis to Present at 25th Annual ROTH Conference
5. Venaxis Advances Pivotal U.S. Study and Accelerates European Market Development for APPY1 Blood-based Appendicitis Test
6. Venaxis Appoints SomaLogic CMO and former Pfizer Executive Stephen A. Williams, M.D., Ph.D., to Board of Directors
7. Venaxis to Present at Canaccord Genuity 33rd Annual Growth Conference
8. Venaxis to Present at Three Upcoming Investor Conferences
9. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. MediPendant™ to Return to Television on May 20th New Television Campaign - Company Provides MediPendant™ Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Tenn. , May 29, 2015  Dr. Yair ... practice to resolve vaginal health issues often caused by menopause. ... and requires no anesthesia, received FDA clearance in 2014. Dr. ... Tennessee to offer the special fractional CO 2 ... as breast cancer survivors. In 2010 there ...
(Date:5/29/2015)... and SPARTANBURG, South Carolina ... Guardian Research Network and Molecular Health have announced a ... molecular diagnostic decision support to the majority of cancer ... Research Network will collaborate with Molecular Health to harness ... to identify cohorts from hundreds of thousands of patients ...
(Date:5/29/2015)... , May 29, 2015 /CNW/ - Covalon Technologies Ltd. ... medical technologies company, is delighted to announce its ... 31, 2015, which includes revenue for three months ... of $264,340. Revenue from advanced wound care product sales ... 2015 increased 24% to $1,742,672 compared to $1,400,065 ...
Breaking Medicine Technology:The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3
... Elekta recently received 510(k) clearance from the U.S. ... software to plan spot scanning. Spot scanning is a ... conformal dose to the tumor by using thousands of ... This approach enables Intensity Modulated Proton Therapy (IMPT). ...
... SAN DIEGO, Dec. 3, 2010 Halozyme ... company developing and commercializing products targeting the extracellular ... Frost, Ph.D., to serve as president and CEO, effective ... CEO and member of the board of directors to ...
Cached Medicine Technology:Elekta Receives FDA 510(k) Clearance for XiO Software to Plan Spot Scanning for Proton Therapy 2Halozyme Therapeutics Realigns Management 2Halozyme Therapeutics Realigns Management 3
(Date:5/29/2015)... (PRWEB) May 29, 2015 John A. ... to Cincinnati , The Department of Veterans Affairs (VA) ... Gennaro as the new director of the Cincinnati VA ... care to more than 43,000 unique Veterans annually and ... over 2,000 staff, CVAMC is a two-division campus located ...
(Date:5/29/2015)... 29, 2015 According to a recent HealthDay ... full-time workers has a substance abuse problem - the data, ... 111,500 adults with full-time jobs, revealed that 9.5% of those ... year. (1) The National Council on Alcoholism and Drug Dependence ... and an estimated 70% of the 14.8 million illicit drug ...
(Date:5/29/2015)... New York, NY (PRWEB) May 29, 2015 ... Pharmaceuticals unit have reached a confidential Risperdal lawsuit ... who allegedly developed gynecomastia due to his use ... the case had been selected for the third ... in a mass tort litigation underway in Pennsylvania’s ...
(Date:5/29/2015)... Inspire Nexus, a new social network officially launching ... many life coaches have asked, "How do I find ... to become a credentialed Coach?" , Many Life and ... long. Inspire Nexus, a social network for Coaches provides ... have experience coaching a certain number of hours, qualify ...
(Date:5/29/2015)... OncLive proudly announces the 2015 ... recognized by a panel of eminent oncologists for landmark ... Honorees will be introduced and celebrated TONIGHT at the ... 8:30-11:00 p.m. CDT at The Chicago Illuminating Company, 2110 ... recognized for groundbreaking accomplishments, in fields including translational research, ...
Breaking Medicine News(10 mins):Health News:VA Healthcare System of Ohio Network Announces New Medical Center Director 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4
... prefer to find out whether their partners HIV Status. This ... prevent catching the disease. The risky behavior of unprotected ... is on the rise. ,In Britain, more than ... they continue to have unprotected sex. The saliva test also ...
... Delhi High Court Wednesday held that the misuse of ambulances ... stressing that their services be availed of only by ... Justice S.N. Agrawal said: "No ambulance of any of the ... by the medical staff for their private use." ...
... she was upset when her pictures appeared in magazine articles ... that blew up, I felt terrible. It appeared that I ... thin because that's what I am, and I was thinner ... else," people.com quotes her as saying to a magazine. ...
... the malfunction of a gene causes schizophrenia and depression ... the journal Neuron. ,The researchers said their findings ... treatments for schizophrenia and depression, which have been proven ... ,In their experiments, the researchers sought to explore ...
... Indira Gandhi National Open University (IGNOU), any university set ... deemed to be university can offer distance education programme ... down by the Distance Education Council (DEC) and other ... 23, 2007 had resolved that it would not insist ...
... P.K. Sreemathi and seven others for culpable homicide not amounting ... a hospital due to infection. ,The court ... a complaint by a person regarding infant deaths at the ... were due to infection the infants contracted in the labour ...
Cached Medicine News:Health News:Unprotected Sex Among the Gays on the Rise 2Health News:Malfunction of Gene Causes Schizophrenia, Depression 2Health News:Kerala Health Minister Charged for Infant Deaths in a Hospital 2
Weight is evenly distributed by fully adjustable velcro straps that cross in the back. Adjustable back velcro keeps apron snug....
Front protection with choice of adjustable 2" buckle or velcro belt which crosses the back for a comfortable fit. Adjustable straps at shoulders keeps apron snug....
The NS242 is a base level constant current Conventional Peripheral Nerve Stimulator only. It uses conventional stimulation patterns only to monitor neuromuscular blocks i.e. Single Twitch, Train of F...
Double cuff electronic tourniquet....
Medicine Products: